Holen Sie sich die Stockscreener-App
158.23
2.00%
3.10
Handel nachbörslich:
158.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$155.13
Offen:
$155.81
24-Stunden-Volumen:
571.84K
Relative Volume:
0.94
Marktkapitalisierung:
$8.58B
Einnahmen:
$1.97B
Nettoeinkommen (Verlust:
$-494.50M
KGV:
-17.16
EPS:
-9.22
Netto-Cashflow:
$137.20M
1W Leistung:
-1.13%
1M Leistung:
-4.21%
6M Leistung:
-8.62%
1J Leistung:
+47.26%
1-Tages-Spanne:
$154.54
$158.48
1-Wochen-Bereich:
$153.36
$161.09
52-Wochen-Spanne:
$101.61
$194.88
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Vergleichen Sie MASI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
158.23 | 8.68B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Masimo Corporation Stock Analysis and ForecastExceptional profit velocity - jammulinksnews.com
Is Masimo Corporation a good long term investmentRemarkable growth - jammulinksnews.com
What analysts say about Masimo Corporation stockFree Popular Stock Recommendations - Jammu Links News
Lobbying Update: $110,000 of MASIMO CORPORATION lobbying was just disclosed - Quiver Quantitative
Masimo Corp. Settles Investor Suit Over Revenue Disclosures - Law360
Samsung to buy US health tech firm Xealth in digital health push - KED Global
Masimo Criticizes Bid To DQ Quinn Emanuel In Payout Suit - Law360
Joe Kiani Appointed CEO of Santa Monica Media Company - Orange County Business Journal
Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years - Benzinga
Masimo Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation - MarketScreener
Masimo Joins Elite American Heart Association Tech Network to Transform Cardiovascular Monitoring - Stock Titan
Apple wants U.S. appeals court to overturn decision that forced it to remove blood-oxygen reading tech from the Apple Watch - MacTech.com
Europe Respiratory Care Devices Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Koninklijke Philips, GE, Masimo, ResMedInc, BD and Co, Chart Industries, Getinge - Yahoo Finance
5 Federal Circuit Clashes To Watch In July - Law360
Piper Sandler reiterates Masimo stock rating, cites new CEO impact By Investing.com - Investing.com South Africa
Masimo Fails to Disqualify Law Firm on Ousted Founder’s Team (1) - Bloomberg Law News
This Week in Chancery Court: Atlas Energy Solutions, Masimo (1) - Bloomberg Law News
Multiple Executive Changes Announced by Masimo; COO Muhsin to Resign July 1 - Strata-gee.com
Masimo COO to Resign - Orange County Business Journal
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties - GlobeNewswire Inc.
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia - marketscreener.com
Rhumbline Advisers Cuts Stock Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
New Masimo CEO Katie Szyman Reveals Personal Ties to Device Maker - Orange County Business Journal
Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand - Law360
Masimo Corp (MASI) Stock Price Up 3.31% on Jun 6 - GuruFocus
Transcript : Masimo Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - MarketScreener
Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today - Benzinga
Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI) - Yahoo Finance
BTIG maintains Buy on Masimo stock with $193 price target - Investing.com India
BTIG maintains Buy on Masimo stock with $193 price target By Investing.com - Investing.com Canada
Masimo Founder Slaps Board With Lawsuit Over His Ouster - Law360
Is the Market Bullish or Bearish on Masimo? - Benzinga
Masimo Updates SEC on Its Progress Recovering From Recent Cyberattack - Strata-gee.com
Masimo (MASI) Reaffirms 2025 Outlook Despite Cybersecurity Incident - GuruFocus
Masimo Corporation: Will The Sound United Divestiture & Financial Realignment Efforts Meet Their Ultimate Goal? - Smartkarma
Masimo Corp (MASI) Trading 3.93% Higher on May 27 - GuruFocus
Masimo (MASI) Reassures Investors on Financial Outlook | MASI Stock News - GuruFocus
Masimo rallies after saying cyber attack won’t hurt 2025 sales - TipRanks
Masimo Corp maintains outlook despite cyber incident By Investing.com - Investing.com South Africa
Masimo Corp maintains outlook despite cyber incident - Investing.com
Masimo Leadership Takes Stage at Jefferies Healthcare Conference: Key Investor Presentation Coming June 4 - Stock Titan
Masimo says cyberattack will not prevent it from fulfilling orders - Cybersecurity Dive
MASI Q1 Earnings Call: Revenue Tops Expectations, Focus Shifts to Healthcare Core Amid Tariff Headwinds - Yahoo Finance
Midday Stock Roundup: RxSight Up 13% on Wells Fargo Upgrade - Orange County Business Journal
Masimo Tells SEC It Was the Victim of a Cyberattack - Strata-gee.com
Masimo Sells Sound United to Harman; Excited? Temper Your Enthusiasm - Strata-gee.com
Transcript : Masimo Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04 - marketscreener.com
Masimo at BofA Healthcare Conference: Strategic Realignment for Growth - Investing.com
Recent Investment Analysts’ Ratings Changes for Masimo (MASI) - Defense World
Do You Believe in the Growth Potential of Masimo Corporation (MASI)? - MSN
INVESTOR ALERT: Potential Recovery for Masimo Corporation (MASI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):